This move aligns with the firm’s strategic focus on developing therapies centered around sodium channel modulation and blockade for pain management. “The specific sodium channel we are targeting, NaV1 ...
Channel Therapeutics Corporation, formerly Chromocell Therapeutics, has rebranded and reincorporated to emphasize its focus on non-opioid pain treatments using sodium channel modulation. The company ...
Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...
Researchers found in-person and self-paced online Emotional Freedom Technique programs to be potentially effective in the management of chronic pain in adults.